Cureous Labs Private Limited

Cureous Labs Private Limited, based in Bangalore, India, specializes in healthcare technology solutions designed to enhance patient care through innovative products that prevent bedsores and bedfalls. Cureous Labs was founded in 2020 in Bangalore, India, and focuses on developing intelligent healthcare solutions. The company has secured INR 16. 6 mn in Seed funding led by Inflection Point Ventures, with involvement from Anthill Ventures as well.

This funding will support their growth initiatives, including manufacturing their first product batch and launching a disinfection center. The founder's background is not specified, and there are no mentions of subsidiaries or significant business pivots. Cureous Labs specializes in innovative healthcare solutions aimed at preventing bedsores and bedfalls through its flagship product, the Eturnal Series. This intelligent automatic patient repositioning system is designed for both home and hospital environments, enabling caregivers to effortlessly reposition patients at the push of a button.

The Eturnal Series integrates advanced technology to ensure effective pressure distribution, helping reduce the risk of pressure injuries while also streamlining the caregiving process. The company targets a diverse client base, including hospitals, assisted living facilities, and individual households, primarily in urban markets across India. Cureous Labs generates revenue through direct-to-consumer sales as well as partnerships with healthcare providers and institutions. Their business model includes selling their flagship Eturnal Series and related products to hospitals and home care markets.

Typically, transactions involve one-time purchases of the repositioning systems, which are priced competitively to cater to both institutional and individual clients. In addition to product sales, the company may also engage in service agreements for ongoing support and maintenance, ensuring that their systems operate effectively over time. In August 2025, Cureous Labs Private Limited raised INR 16. 6 mn in Seed funding led by Inflection Point Ventures, with participation from Anthill Ventures.

The company plans to use this funding to manufacture its first product batch, build inventory, expand sales and business development, launch a disinfection center, and complete safety testing and certifications.